ACON Stock Analysis: Buy, Sell, or Hold?
ACON - Aclarion, Inc. Common Stock
$3.41
0.14 (4.28%)
▲
5d:
+5.57%
30d:
+27.24%
90d:
-23.54%
BUY
MODERATE Confidence
Analysis Updated: Apr 1, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When ACON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ACON shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ACON shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ACON is currently trading at $3.41, which is considered extended relative to its 30-day fair value range of $2.82 to $3.38.
Technical Outlook: Technically, ACON is in a strong downtrend. Immediate support is located at $3.03, while resistance sits at $3.60. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: ACON has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.00 (+545.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACON is in a strong downtrend. Immediate support is located at $3.03, while resistance sits at $3.60. The stock is showing strong short-term momentum, up 4.3% recently.
Market Sentiment: ACON has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $22.00 (+545.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$2.82 -
$3.38
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
68.4%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.3%)
- BULLISH: Trading 545.2% below Wall St target ($22.00)
Fair Price Analysis
30-Day Fair Range
$2.82 -
$3.38
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$3.03
Resistance Level
$3.60
Current Trend
Strong Downtrend
Technical data as of
Apr 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.26
Wall Street Target
$22.00
(+545.2%)
Revenue Growth (YoY)
76.1%
Share & Embed Analysis
Last updated: April 02, 2026 7:55 AM ET
Data refreshes hourly during market hours. Next update: 8:55 AM
Data refreshes hourly during market hours. Next update: 8:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACON showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Brent Ness
BUY
10 shares
2025-11-26
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$271 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$32 | 61 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 65 BUY |
|
HQY
HealthEquity Inc |
STRONG BUY
14 analysts |
$112 | 66 BUY |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$28 | 53 HOLD |
